Can PDRN serums and ampoules replace injectable treatments?

Not entirely, but the gap is narrower than expected. A 2026 PMC review found topical PDRN achieves approximately 78% of injectable efficacy overall. For wrinkle depth reduction specifically, injectables showed 67% improvement versus 52% for topical application. For maintenance between clinic visits or for those avoiding needles, topical PDRN is a meaningful option.

Is PDRN safe for people with salmon allergies?

PDRN is highly purified salmon DNA with allergenic proteins like parvalbumin removed in the extraction process. Clinical tolerance is generally good. However, individuals with significant salmon allergies should patch test first and consult a dermatologist before use.

What should I look for when buying a PDRN product?

Look for 'PDRN' or 'polydeoxyribonucleotide' on the ingredient label with concentration typically in the 0.1 to 1% range. Products using Korean MFDS-approved raw materials generally have stronger documentation. PDRN and PN (polynucleotide) are related but distinct, so check which term is used and at what molecular weight.

PDRN Polynucleotide: K-Beauty's New Paradigm in Skin Regeneration

When Korean dermatology clinics began offering injections under the name “Rejuran Healer” in the early 2010s, the active ingredient was a highly purified extract from salmon sperm: PDRN, or polydeoxyribonucleotide. What started as a clinic-only procedure has since evolved into one of the most discussed ingredients in global premium skincare, with topical serums, ampoules, and pads now available worldwide. A 2026 review in the Journal of Cosmetic Dermatology, indexed in PMC, provides the most comprehensive analysis of PDRN’s mechanisms and clinical performance to date.

What PDRN Actually Is

PDRN is produced by extracting DNA from salmon testis, then enzymatically fragmenting it into short nucleotide chains ranging from approximately 50 to 2,000 kDa in molecular weight. This molecular size range is key to its biological activity: large enough for receptor interactions, small enough for meaningful percutaneous absorption.

The primary mechanism operates through the purine salvage pathway. Cells take up the DNA fragments and break them down into raw nucleotide materials, which are then reused for DNA repair, cellular proliferation, and energy metabolism. Additionally, PDRN activates A2A adenosine receptors, triggering an anti-inflammatory signaling cascade that distinguishes it from simpler moisturizing ingredients.

The Clinical Record Built by Korean Dermatology

Korean clinics established PDRN’s clinical profile through injectable skin booster applications before the global skincare market became interested. The 2026 PMC review analyzed cumulative data from multiple controlled trials. Injectable PDRN demonstrated an average 67% improvement in wrinkle depth, with effects on fibroblast activity, collagen and elastin synthesis, and angiogenesis (new blood vessel formation) consistently documented.

Anti-inflammatory applications have expanded beyond aesthetics. PDRN injections have shown efficacy in atopic dermatitis, post-acne scarring, and wound healing contexts, with multiple formulations holding Korean MFDS approval. Hair regrowth applications are an active area of clinical investigation, with early data supporting scalp vessel formation and follicle environment improvement.

Topical Reaches 78% of Injectable Results

The central question for the global consumer market has been whether serums and ampoules can deliver what needles have proven. According to the 2026 review, the answer is closer than expected: topical PDRN achieves approximately 78% of injectable efficacy in aggregate outcomes, with 52% wrinkle depth improvement versus 67% for injectables.

This has driven investment in delivery technology. Nanosome and liposome encapsulation, penetrating peptide carriers, and microneedle patch combinations are all being used to increase dermal penetration. Clinical-grade home devices that use ultrasound or low-frequency vibration to assist absorption are increasingly paired with PDRN topicals in professional recommendations.

Hypopigmentation, Wound Healing, and Hair

Beyond collagen and wrinkle metrics, PDRN’s mechanism creates a broader application profile. Melanin synthesis inhibition through the A2A receptor pathway has been studied for hyperpigmentation reduction, with data emerging for both injectable and topical routes. Wound closure studies show accelerated healing timelines when PDRN is applied to surgical and traumatic wounds. The anti-inflammatory effect has been particularly relevant for rosacea-adjacent applications, where chronic low-grade inflammation drives visible redness.

How K-Beauty Ingredients Travel

PDRN’s path from Korean clinics to global skincare shelves follows the same arc as niacinamide, centella asiatica, and panthenol before it. Korean dermatology establishes clinical data through clinic use, that data supports ingredient adoption in Korean consumer products, and then global brands follow. The ingredient is now appearing in premium lines across Japan, Southeast Asia, and increasingly in European and North American launches. When evaluating products, PDRN concentration (0.1 to 1%), source documentation, and delivery technology are the three criteria that separate meaningful formulations from label marketing.

Source: PMC / J Cosmetic Dermatology